ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

CUE Cue Biopharma Inc

2.13
0.25 (13.30%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cue Biopharma Inc CUE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.25 13.30% 2.13 17:10:12
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.90 1.87 2.19 2.13 1.88
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202409:01GLOBECue Biopharma to Present at the 2024 American Society of..
08/4/202415:05GLOBECue Biopharma Reports Fourth Quarter and Full Year 2023..
02/4/202407:00GLOBECue Biopharma to Host Business Update Call and Webcast
08/3/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202409:00GLOBECue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured..
22/2/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202407:00GLOBECue Biopharma to Present Corporate Update at the..
04/1/202415:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202307:00GLOBECue Biopharma to Present at the JMP Securities Hematology..
09/11/202315:05GLOBECue Biopharma Reports Third Quarter 2023 Financial Results..
07/11/202307:00GLOBECue Biopharma to Present at Three Upcoming Investor..
03/11/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202311:00GLOBECue Biopharma Presents New Positive Data from Phase 1 Trials..
02/11/202307:00GLOBECue Biopharma to Host Business Update Call and Webcast
27/9/202308:05GLOBECue Biopharma Announces Upcoming Scientific Presentations at..
26/9/202307:00GLOBECue Biopharma Announces Completion of Patient Enrollment in..
14/9/202315:01EDGAR2Form 8-K - Current report
29/8/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:10GLOBECue Biopharma Reports Second Quarter 2023 Financial Results..
08/8/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202307:00GLOBECue Biopharma to Host Business Update Call and Webcast
25/7/202311:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202311:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202311:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202311:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202307:00GLOBECue Biopharma to Present at the Federation of Clinical..
07/6/202307:00GLOBECue Biopharma to Host Investor Call
05/6/202307:00GLOBECue Biopharma to Present at the Jefferies 2023 Global..
25/5/202316:00GLOBECue Biopharma Presents Positive Data Update from Ongoing..
15/5/202307:00GLOBECue Biopharma to Present at the 2023 American Society of..
09/5/202315:35GLOBECue Biopharma Reports First Quarter 2023 Financial Results..
08/5/202307:00GLOBECue Biopharma to Present at the Upcoming JMP Securities Life..

Su Consulta Reciente

Delayed Upgrade Clock